Font Size:
a
A
A
Keyword [Specific Immunotherapy]
Result: 81 - 93 | Page: 5 of 5
81.
Sublingual Specific Immunotherapy For Allergic Rhinitis In Children Aged 4-12 Years With Different Medication Time Points Efficacy Analysis
82.
Clinical Efficacy Of Sublingual Immunotherapy In Treatment Course Of Allergic Rhinitis
83.
Current Status Of Knowledge,Belief And Practice Of Subcutaneous Specific Immunotherapy In Patients With Dust Mite Allergy And Analysis Of Related Factors
84.
Tfh And Breg Cells In Immunotherapy With Alternaria Alternata And Analysis Of The Endotypes In Alternaria-induced Asthma Patients
85.
TLR7/8 Agonists-based Multimodal Nano-delivery Platform For Tumor-specific Immunotherapy
86.
Effect Of Sublingual Immunotherapy On Asthmatic Children With Dust Mite
87.
Mechanism Of OVA Nanovaccine With TLR7 Agonist(R848)as Adjuvant In The Treatment Of OVA-induced Allergic Asthma
88.
The Expression Of BDNF In Allergic Rhinitis And Its Efficacy Evaluation On Subcutaneous Immunotherapy With House Dust Mite
89.
The Effect And Mechanism Of Platelet Rich Plasma Combined With Specific Immunotherapy On Murine Asthma Model
90.
Efficacy And Safety Study Of Subcutaneous Specific Immunotherapy In Allergic Rhinitis
91.
Clinical Efficacy And Safety Analysis Of Subcutaneous Specific Immunotherapy For Multiple Allergic Rhinitis
92.
The Efficacy Of Standardized Allergen Subcutaneous Specific Immunotherapy In Children With Monosensitized Versus Polysensitized Allergic Asthma
93.
Establishment Of An Atopic Dermatitis-like Mouse Model With House Dust Mite Sensitization And Observation Of The Curative Effect Of Allergen-specific Immunotherapy
<<First
<Prev
Next>
Last>>
Jump to